List of Tables
Table 1. Global Alternative to Antibiotics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Alternative to Antibiotics Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Alternative to Antibiotics Market Competitive Situation by Manufacturers in 2024
Table 4. Global Alternative to Antibiotics Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Alternative to Antibiotics Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Alternative to Antibiotics Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Alternative to Antibiotics Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Alternative to Antibiotics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Alternative to Antibiotics, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Alternative to Antibiotics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Alternative to Antibiotics, Product Type & Application
Table 12. Global Key Manufacturers of Alternative to Antibiotics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Alternative to Antibiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alternative to Antibiotics as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Alternative to Antibiotics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Alternative to Antibiotics Sales by Region (2020-2025) & (K Units)
Table 18. Global Alternative to Antibiotics Sales Market Share by Region (2020-2025)
Table 19. Global Alternative to Antibiotics Sales by Region (2026-2031) & (K Units)
Table 20. Global Alternative to Antibiotics Sales Market Share by Region (2026-2031)
Table 21. Global Alternative to Antibiotics Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Alternative to Antibiotics Revenue Market Share by Region (2020-2025)
Table 23. Global Alternative to Antibiotics Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Alternative to Antibiotics Revenue Market Share by Region (2026-2031)
Table 25. North America Alternative to Antibiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Alternative to Antibiotics Sales by Country (2020-2025) & (K Units)
Table 27. North America Alternative to Antibiotics Sales by Country (2026-2031) & (K Units)
Table 28. North America Alternative to Antibiotics Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Alternative to Antibiotics Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Alternative to Antibiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Alternative to Antibiotics Sales by Country (2020-2025) & (K Units)
Table 32. Europe Alternative to Antibiotics Sales by Country (2026-2031) & (K Units)
Table 33. Europe Alternative to Antibiotics Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Alternative to Antibiotics Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Alternative to Antibiotics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Alternative to Antibiotics Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Alternative to Antibiotics Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Alternative to Antibiotics Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Alternative to Antibiotics Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Alternative to Antibiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Alternative to Antibiotics Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Alternative to Antibiotics Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Alternative to Antibiotics Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Alternative to Antibiotics Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Alternative to Antibiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Alternative to Antibiotics Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Alternative to Antibiotics Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Alternative to Antibiotics Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Alternative to Antibiotics Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Alternative to Antibiotics Sales (K Units) by Type (2020-2025)
Table 51. Global Alternative to Antibiotics Sales (K Units) by Type (2026-2031)
Table 52. Global Alternative to Antibiotics Sales Market Share by Type (2020-2025)
Table 53. Global Alternative to Antibiotics Sales Market Share by Type (2026-2031)
Table 54. Global Alternative to Antibiotics Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Alternative to Antibiotics Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Alternative to Antibiotics Revenue Market Share by Type (2020-2025)
Table 57. Global Alternative to Antibiotics Revenue Market Share by Type (2026-2031)
Table 58. Global Alternative to Antibiotics Price (USD/Unit) by Type (2020-2025)
Table 59. Global Alternative to Antibiotics Price (USD/Unit) by Type (2026-2031)
Table 60. Global Alternative to Antibiotics Sales (K Units) by Application (2020-2025)
Table 61. Global Alternative to Antibiotics Sales (K Units) by Application (2026-2031)
Table 62. Global Alternative to Antibiotics Sales Market Share by Application (2020-2025)
Table 63. Global Alternative to Antibiotics Sales Market Share by Application (2026-2031)
Table 64. Global Alternative to Antibiotics Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Alternative to Antibiotics Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Alternative to Antibiotics Revenue Market Share by Application (2020-2025)
Table 67. Global Alternative to Antibiotics Revenue Market Share by Application (2026-2031)
Table 68. Global Alternative to Antibiotics Price (USD/Unit) by Application (2020-2025)
Table 69. Global Alternative to Antibiotics Price (USD/Unit) by Application (2026-2031)
Table 70. DSM Company Information
Table 71. DSM Description and Business Overview
Table 72. DSM Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. DSM Alternative to Antibiotics Product
Table 74. DSM Recent Developments/Updates
Table 75. DuPont(Danisco) Company Information
Table 76. DuPont(Danisco) Description and Business Overview
Table 77. DuPont(Danisco) Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. DuPont(Danisco) Alternative to Antibiotics Product
Table 79. DuPont(Danisco) Recent Developments/Updates
Table 80. Chr. Hansen Company Information
Table 81. Chr. Hansen Description and Business Overview
Table 82. Chr. Hansen Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Chr. Hansen Alternative to Antibiotics Product
Table 84. Chr. Hansen Recent Developments/Updates
Table 85. Lallemand Company Information
Table 86. Lallemand Description and Business Overview
Table 87. Lallemand Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Lallemand Alternative to Antibiotics Product
Table 89. Lallemand Recent Developments/Updates
Table 90. China-Biotics Company Information
Table 91. China-Biotics Description and Business Overview
Table 92. China-Biotics Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. China-Biotics Alternative to Antibiotics Product
Table 94. China-Biotics Recent Developments/Updates
Table 95. Nestle Company Information
Table 96. Nestle Description and Business Overview
Table 97. Nestle Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Nestle Alternative to Antibiotics Product
Table 99. Nestle Recent Developments/Updates
Table 100. Danone Company Information
Table 101. Danone Description and Business Overview
Table 102. Danone Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Danone Alternative to Antibiotics Product
Table 104. Danone Recent Developments/Updates
Table 105. Probi Company Information
Table 106. Probi Description and Business Overview
Table 107. Probi Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Probi Alternative to Antibiotics Product
Table 109. Probi Recent Developments/Updates
Table 110. BioGaia Company Information
Table 111. BioGaia Description and Business Overview
Table 112. BioGaia Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. BioGaia Alternative to Antibiotics Product
Table 114. BioGaia Recent Developments/Updates
Table 115. Yakult Company Information
Table 116. Yakult Description and Business Overview
Table 117. Yakult Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Yakult Alternative to Antibiotics Product
Table 119. Yakult Recent Developments/Updates
Table 120. Novozymes Company Information
Table 121. Novozymes Description and Business Overview
Table 122. Novozymes Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Novozymes Alternative to Antibiotics Product
Table 124. Novozymes Recent Developments/Updates
Table 125. Valio Company Information
Table 126. Valio Description and Business Overview
Table 127. Valio Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Valio Alternative to Antibiotics Product
Table 129. Valio Recent Developments/Updates
Table 130. Glory Biotech Company Information
Table 131. Glory Biotech Description and Business Overview
Table 132. Glory Biotech Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Glory Biotech Alternative to Antibiotics Product
Table 134. Glory Biotech Recent Developments/Updates
Table 135. Ganeden Company Information
Table 136. Ganeden Description and Business Overview
Table 137. Ganeden Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Ganeden Alternative to Antibiotics Product
Table 139. Ganeden Recent Developments/Updates
Table 140. Morinaga Milk Industry Company Information
Table 141. Morinaga Milk Industry Description and Business Overview
Table 142. Morinaga Milk Industry Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Morinaga Milk Industry Alternative to Antibiotics Product
Table 144. Morinaga Milk Industry Recent Developments/Updates
Table 145. Sabinsa Company Information
Table 146. Sabinsa Description and Business Overview
Table 147. Sabinsa Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Sabinsa Alternative to Antibiotics Product
Table 149. Sabinsa Recent Developments/Updates
Table 150. Greentech Company Information
Table 151. Greentech Description and Business Overview
Table 152. Greentech Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Greentech Alternative to Antibiotics Product
Table 154. Greentech Recent Developments/Updates
Table 155. Bioriginal Company Information
Table 156. Bioriginal Description and Business Overview
Table 157. Bioriginal Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Bioriginal Alternative to Antibiotics Product
Table 159. Bioriginal Recent Developments/Updates
Table 160. Biosearch Life Company Information
Table 161. Biosearch Life Description and Business Overview
Table 162. Biosearch Life Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. Biosearch Life Alternative to Antibiotics Product
Table 164. Biosearch Life Recent Developments/Updates
Table 165. UAS Laboratories Company Information
Table 166. UAS Laboratories Description and Business Overview
Table 167. UAS Laboratories Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. UAS Laboratories Alternative to Antibiotics Product
Table 169. UAS Laboratories Recent Developments/Updates
Table 170. Synbiotech Company Information
Table 171. Synbiotech Description and Business Overview
Table 172. Synbiotech Alternative to Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 173. Synbiotech Alternative to Antibiotics Product
Table 174. Synbiotech Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Alternative to Antibiotics Distributors List
Table 178. Alternative to Antibiotics Customers List
Table 179. Alternative to Antibiotics Market Trends
Table 180. Alternative to Antibiotics Market Drivers
Table 181. Alternative to Antibiotics Market Challenges
Table 182. Alternative to Antibiotics Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
Table 186. Authors List of This Report
List of Figures
Figure 1. Product Picture of Alternative to Antibiotics
Figure 2. Global Alternative to Antibiotics Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Alternative to Antibiotics Market Share by Type: 2024 & 2031
Figure 4. Antimicrobial Proteins Product Picture
Figure 5. Bacteriophages Product Picture
Figure 6. Probiotics Product Picture
Figure 7. Other Product Picture
Figure 8. Global Alternative to Antibiotics Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Alternative to Antibiotics Market Share by Application: 2024 & 2031
Figure 10. Food & Beverage
Figure 11. Drugs
Figure 12. Dietary Supplements
Figure 13. Global Alternative to Antibiotics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Alternative to Antibiotics Market Size (2020-2031) & (US$ Million)
Figure 15. Global Alternative to Antibiotics Sales (2020-2031) & (K Units)
Figure 16. Global Alternative to Antibiotics Average Price (USD/Unit) & (2020-2031)
Figure 17. Alternative to Antibiotics Report Years Considered
Figure 18. Alternative to Antibiotics Sales Share by Manufacturers in 2024
Figure 19. Global Alternative to Antibiotics Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Alternative to Antibiotics Players: Market Share by Revenue in Alternative to Antibiotics in 2024
Figure 21. Alternative to Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Alternative to Antibiotics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Alternative to Antibiotics Sales Market Share by Country (2020-2031)
Figure 24. North America Alternative to Antibiotics Revenue Market Share by Country (2020-2031)
Figure 25. United States Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Alternative to Antibiotics Sales Market Share by Country (2020-2031)
Figure 28. Europe Alternative to Antibiotics Revenue Market Share by Country (2020-2031)
Figure 29. Germany Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Alternative to Antibiotics Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Alternative to Antibiotics Revenue Market Share by Region (2020-2031)
Figure 36. China Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Alternative to Antibiotics Sales Market Share by Country (2020-2031)
Figure 46. Latin America Alternative to Antibiotics Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Alternative to Antibiotics Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Alternative to Antibiotics Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Alternative to Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Alternative to Antibiotics by Type (2020-2031)
Figure 56. Global Revenue Market Share of Alternative to Antibiotics by Type (2020-2031)
Figure 57. Global Alternative to Antibiotics Price (USD/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Alternative to Antibiotics by Application (2020-2031)
Figure 59. Global Revenue Market Share of Alternative to Antibiotics by Application (2020-2031)
Figure 60. Global Alternative to Antibiotics Price (USD/Unit) by Application (2020-2031)
Figure 61. Alternative to Antibiotics Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
